|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 31/192 | (2013.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 9/0092 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61F 9/0017 | (2013.01) | ||
| A61K 31/165 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 38/13 | (2006.01) | ||
| A61K 38/13 | (2013.01) | ||
| A61K 47/26 | (2013.01) | ||
| A61F 9/00 | (2006.01) | ||
| A61L 27/54 | (2006.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61K 9/0051 | (2013.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61K 9/146 | (2013.01) | ||
| A61P 27/12 | (2018.01) | ||
| A61K 31/165 | (2013.01) | ||
| A61P 27/04 | (2018.01) | ||
| A61K 31/573 | (2013.01) | ||
| A61K 31/405 | (2013.01) | ||
| A61F 9/00772 | (2013.01) | ||
| A61K 47/34 | (2013.01) |
| (11) | Number of the document | 3518897 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17857601.3 |
| Date of filing the European patent application | 2017-09-30 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/054654 |
| Date | 2017-09-30 |
| (87) | Number | WO 2018/064648 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662402938 P | 2016-09-30 | US |
| (72) |
UTKHEDE, Deepank , CA
JONES, Catherine , CA
WISEMAN, David , CA
|
| (73) |
Mati Therapeutics Inc. ,
4317 Dunning Lane, Austin, TX 78746,
US
|
| (54) | OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF |
| OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF |